Taken together, these results demonstrated that upregulation of SP1 is associated with YAP/TEAD transcriptional activity, and such upregulation of SP1 could dampen the antitumor immunity through the transcriptional activation of VISTA in CRC (Fig. 7F). This evidence concerns the gene SP1 and colorectal carcinoma.